BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling

The bromodomain and extra-terminal domain (BET) protein BRD4 is emerging as a potential target for Cancer therapy. However, BRD4 roles in regulating the stemness of gastric Cancer cells are unclear. Here, we demonstrated that BRD4 expression was significantly increased in gastric Cancer tissues, cell spheroids, and BRD4 knockdown attenuated the stemness of gastric Cancer cells characterized as the decrease of stemness markers expression, capacity of cells spheroids formation and ALDH1 activity. Importantly, BRD4 expression was negatively correlated with overall survival, first progression survival and post progression survival of gastric Cancer patients. Mechanistic investigations revealed that miR-216a-3p was the most remarkably upregulated miRNA in response to BRD4 knockdown and Wnt/β-catenin signaling was necessary for BRD4-mediated promotion on the stemness of gastric Cancer cells. Additionally, BRD4 directly bound to the promoter and promoted the methylation level of MIR216A promoter, thus decreasing miR-216a-3p level. Notably, Wnt3a was identified as the direct target of miR-216a-3p in gastric Cancer cells. Therefore, our results defined a BRD4/miR-216a-3p/Wnt/β-catenin pathway in regulating the stemness of gastric Cancer cells.